Loading...

ANIK ANIKA THERAPEUTICS INC Expansion Plans 8-K Filing

NK T

NK

ANIKA THERAPEUTICS INC

(ANIK)

2025 8-K

Leadership Transition

Leadership Transition

Financial Update

Financial Statements

Product Expansion

Appointing directors

Financial Statements

Management Change

Financial Results

Q3 Financial Results

Earnings Reports

Annual Meeting of Stockholders

Cooperation Agreement and B...

Appointment of CFO

Earnings Reports

Earnings Reports

Retirement of Director

Earnings Reports

Investor Conferences

Earnings Reports

Amendment and Appointment

Earnings Reports

Settlement Agreement

Cooperation Agreement

External Links:

On November 5, 2025, Anika Therapeutics, Inc. announced its third-quarter financial results and filed the last module of its Premarket Approval application for Hyalofast, reporting results from its Phase III FastTRACK clinical trial.

AI Assistant

ANIKA THERAPEUTICS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.